WILSON TROY EDWARD sold 8.4% of their position (5K shares) of PUMA BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $45.5K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/17/2026ACC: 0001437749-26-030597
Director
Since Jun 2019
-5K
Net shares
Net seller
$45.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
5K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−5K
Price / share
$9.10
Trade value
$45.50K
% of position
8.4%
9/14/2026
59.75K→54.75K
Total
Net shares
−5K
Net value
-$45.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2026 | S · Sale | −5K | $9.10 | $45.50K | 8.4% | 59.75K | 54.75K |
| Total | −5K | -$45.50K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned150.00
Common Stock
IndirectShares owned400.00
Total
550.00 indirect550.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 150.00 | Indirect |
| Common Stock | 400.00 | Indirect |
| Total | 550.00 | 550.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported